In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics

American Journal of Otology

Volumn 17, Issue 2, 1996, Pages 207-209

  Dohar, Joseph E ^a   Kenna, Margaret A ^a   Wadowsky, Robert M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Neomycin; Ototoxicity; Pseudomonas aeruginosa

Indexed keywords

COLISTIN; NEOMYCIN; NORFLOXACIN; POLYMYXIN B;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; EXTERNAL OTITIS; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; OTOTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID OTORRHEA; CHILD, PRESCHOOL; EAR, MIDDLE; FEMALE; HUMANS; MALE; OTITIS MEDIA WITH EFFUSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029982355     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Korvick J, Yu VI, Hilf M. Susceptibility of 100 blood isolates of P. aeruginosa to 19 antipseudomonal antibiotics: old and new. Diagn Microbiol Infect Dis 1987;7:107-111.
2. Wright CG, Meyerhoff WL, Halama AR. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol 1987;8(6):495-499.
3. Meyerhoff WL, Morizono T, Wright CG, Shaddock LC, Shea DA, Sikora MA. Tympanostomy tubes and otic drops. Laryngoscope 1983;93:1022-1027.
4. Yu VL, Vickers RM, Zuravleff JJ. Comparative susceptibilities to moxalactam and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother 1980;17:96-8.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved standard. NCCLS document M2-A5. Villanova, PA: NCCLS, 1993.
6. Faden H, Bernstein J, Brodsky L, Stanievich J, Ogra PL. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol 1992;101:87-91.
7. Dohar JE, Kenna MA, Wadowsky RM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg 1995;121:1022-5.
8. Said AA, Livermore DM, Williams RJ. Expression of H1 outer-membrane protein of Pseudomonas aeruginosa in relation to sensitivity to EDTA and polymyxin B. J Med Microbiol 1987;24(3):267-274.
9. Ikeda K, Takasaka T. In vitro activity of ototopical drops against middle ear pathogens. Am J Otol 1993;14:170-171.
10. Gelender II, Rettich C. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers. Cornea 1984;3:21-26.
11. Barlow D, Duckert LG, Kreig CS, Gates GA. Ototoxicity of topical antimicrobial agents. Acta Otolaryngol (Stockh) 1994;115:231-5.